Breast Cancer Studies To Be Presented At American Society Of Clinical Oncology Meeting
medicalnewstoday.com     May 20, 2008            

Several recently released breast cancer-related studies are scheduled to be presented later this month at the annual meeting of the American Society of Clinical Oncology. Summaries appear below. ~ Herceptin/Tykerb: The combination of breast cancer drugs Herceptin and Tykerb delayed the time it... [read full story]                    


View all news articles about*:
Advisory Beauty Board Body Breast Cancer Cancers Care Company Diseases Female Fitness Genentech GlaxoSmithKline Gralow Health Julie Location Medicines Nutrition Oncology Patients Pharmaceuticals Products Remedies Supplements Therapy Treatments Vitamins
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Documenting Pain as the Fifth Vital Sign: A Feasibility Study in an Oncology Ward in Sarawak,...

karger.com     7 hrs ago          

Department of Radiotherapy and Oncology, Kuching, Sarawak, Malaysia Abstract Background: Monitoring acute postoperative pain as the fifth vital sign is currently practiced in many developed countries. In Sarawak, pain...                    

comments

                   

DiagnoCure Receives Approval from the U.S. Regulatory Authorities and Launches its Previstage(TM)...

biospace.com     yesterday   1 related          

QUEBEC CITY, Aug. 26 /PRNewswire-FirstCall/ - DiagnoCure Oncology Laboratories, based in West Chester, PA, a wholly-owned subsidiary of DiagnoCure Inc., announced today that it has received the U.S. CLIA certification...                    

comments

                   

Prophylactic mastectomies on the rise

msn.com     yesterday          

Like Christina Applegate, more women are choosing prophylactic mastectomies. Last November, Rachel Meiser, a 33-year-old nurse, learned that she had a cancerous lump in her right breast. Like Meiser and, more recently,...                    

comments

                   

Amgen Ends Some Aranesp Pricing Practices

pharmalot.com     Aug 28, 2008   4 related          

The biotech is responding to practices that were criticized for contributing to overuse of its flagship anemia drug at the same time safety concerns were growing, The New York Times reports. Specifically, Amgen will no...                    

comments